Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORCEPT THERAPEUTICS INCCORT · Entity 2620 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORCEPT THERAPEUTICS INC
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.69 · Expires 2036-05-21 | Direct | 12,500 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 12,500 · Balance 12,500 F1: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 21:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 12,500 | $0.00 Strike: $59.69 | $0.00 |
DisclosureSEC source: 0001201715-26-000010 · form4-05262026_090539.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2036-05-21 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 21:07 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 24,218 | $33.56 | $812,836.00 |
DisclosureSEC source: 0001201715-26-000007 · form4-03192026_090326.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,146,631 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.44 to $33.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 21:07 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 75,782 | $33.00 | $2,500,972.72 |
DisclosureSEC source: 0001201715-26-000007 · form4-03192026_090326.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,122,413 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.43 to $33.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $15.15 | $0.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 12 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over one-year period. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 25,000 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 11 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2029-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over one-year period. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 25,000 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 10 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2028-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $12.13 | $0.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 9 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 8 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable ratably on each monthly anniversary of June 27, 2016 over one-year period. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $15.15 | $454,500.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 5 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,095,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 25,000 | $10.50 | $262,500.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 4 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,065,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 25,000 | $14.08 | $352,000.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 3 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,040,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $12.13 | $363,900.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,015,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $5.86 | $175,800.00 |
DisclosureSEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 985,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:11 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001201715-26-000003 · form4-01052026_110112.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| June 10, 2025 Filed Jun 13, 2025 00:08 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 15,000 | $0.00 Strike: $72.27 | $0.00 |
DisclosureSEC source: 0001225208-25-005922 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-06-10 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to the Reporting Person's continued service on each monthly venting date. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 23:03 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000061 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| May 17, 2024 Filed May 21, 2024 22:25 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $28.09 | $0.00 |
DisclosureSEC source: 0001225208-24-006289 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-16 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 17, 2024 over a one-year period. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:58 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007580 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:25 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001225208-23-006179 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthy anniversary of May 19, 2023 over a one-year period. Read SEC document |
| January 01, 2023 Filed Feb 13, 2024 21:46 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003184 · doc5.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By limited partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| June 10, 2022 Filed Feb 14, 2023 23:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 3 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046,631 F3 · kind: Represents the gift of shares from the Reporting Person's direct holdings to the trust described in footnote (4) for no consideration. Read SEC document |
| June 10, 2022 Filed Feb 14, 2023 23:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 955,262 F3 · kind: Represents the gift of shares from the Reporting Person's direct holdings to the trust described in footnote (4) for no consideration. F4 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 21:11 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 20,000 | $0.00 Strike: $20.84 | $0.00 |
DisclosureSEC source: 0001225208-22-007612 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-30 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 31, 2022 over a one-year period. Read SEC document |
| January 01, 2022 Filed Feb 14, 2023 23:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By limited partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 100,000 | $21.53 | $2,153,000.00 |
DisclosureSEC source: 0001225208-21-009444 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,308,303 F3 · shares: These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by Saunders Holdings, L.P. constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares. F4 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 50,000 | $21.53 | $1,076,500.00 |
DisclosureSEC source: 0001225208-21-009444 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046,838 F1 · shares: These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by the Reporting Person's Roth IRA constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares. F2 · balance_after: The number of shares reported as directly held reflects the reduction of shares previously reported by the Reporting Person as held for the exclusive benefit of SHM, to the extent of the shares acquired by Saunders Holdings, L.P., as described in footnote. Read SEC document |
| May 26, 2021 Filed May 28, 2021 22:24 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right To Buy) · Derivative | 20,000 | $0.00 Strike: $21.45 | $0.00 |
DisclosureSEC source: 0001225208-21-008670 · doc4.xml · derivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-25 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over one-year period. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $6.55 | $0.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 12 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2025-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F5 · derivative.exercise_date: Immediately exercisable. F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $4.05 | $0.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 11 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F5 · derivative.exercise_date: Immediately exercisable. F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 10 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2021-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F5 · derivative.exercise_date: Immediately exercisable. F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 9 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2023-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F5 · derivative.exercise_date: Immediately exercisable. F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right To Buy) · Derivative | 30,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 8 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F5 · derivative.exercise_date: Immediately exercisable. F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $1.74 | $52,200.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 5 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. F2 · ownership.direct: As described in footnote (1), includes an aggregate of 150,000 shares held for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of such shares. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $1.74 | $52,200.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 4 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $4.05 | $121,500.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 3 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,086,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $4.42 | $132,600.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,056,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 30,000 | $6.55 | $196,500.00 |
DisclosureSEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| January 01, 2021 Filed Feb 15, 2022 01:12 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009572 · doc5.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By limited partnership Disclosed balance after: 3,308,303 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 00:41 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 68 | $22.64 | $1,539.52 |
DisclosureSEC source: 0001225208-20-014182 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,208,303 F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 00:41 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 1,109 | $22.80 | $25,285.20 |
DisclosureSEC source: 0001225208-20-014182 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,208,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.52 to $22.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 25, 2020 Filed Dec 1, 2020 00:46 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 361 | $22.81 | $8,232.79 |
DisclosureSEC source: 0001225208-20-013993 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,207,126 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.60 to $22.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 01:06 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 1,429 | $22.93 | $32,765.83 |
DisclosureSEC source: 0001225208-20-013905 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,206,765 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8163 to $23.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 01:06 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 1,551 | $22.93 | $35,561.95 |
DisclosureSEC source: 0001225208-20-013905 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,205,336 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.91 to $22.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 00:48 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 2,372 | $17.91 | $42,490.58 |
DisclosureSEC source: 0001225208-20-013700 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,203,785 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.75 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 00:43 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 7,883 | $17.82 | $140,468.75 |
DisclosureSEC source: 0001225208-20-013617 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,201,413 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.72 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 13, 2020 Filed Nov 18, 2020 00:43 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 200 | $17.94 | $3,588.00 |
DisclosureSEC source: 0001225208-20-013617 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,193,530 F1 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:07 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 15,000 | $17.71 | $265,635.00 |
DisclosureSEC source: 0001225208-20-013478 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,193,330 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.47 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 23:07 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 3,786 | $17.96 | $68,013.22 |
DisclosureSEC source: 0001225208-20-013478 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,178,330 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.88 to $17.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 06, 2020 Filed Nov 11, 2020 01:21 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 13,500 | $17.98 | $242,665.20 |
DisclosureSEC source: 0001225208-20-013344 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,174,544 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.90 to $17.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 00:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | PurchaseCommon Stock | 25,807 | $12.50 | $322,525.56 |
DisclosureSEC source: 0001225208-20-011150 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,161,044 F1 · kind: The purchases reported in this Form 4 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the sales of shares by the reporting person, to the extent of the reporting person's pecuniary interest therein, at prices ranging from $15.76 to $15.7602, inclusive, on May 28, 2020. The reporting person has agreed to pay to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.45 to $12.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.